Outcomes in Glioblastoma Patients: From Diagnosis to Palliation
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 1 December 2024 | Viewed by 3109
Special Issue Editors
Interests: functional neurosurgery; cerebrovascular disease; neuro-oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
One of the most challenging aspects in the treatment of high grade glioma (HGG) is the outcome assessment and the subsequent prognostic prevision. With the advancement of technical possibilities, it becomes fundamental to pursue a patient-tailored approach that takes into account a multitude of variables, including clinical, radiological, biomolecular and personal factors. This is particularly true for HGG patients that face the tremendous impact of such an aggressive tumor, as at each step of cure, a fundamental decision has to be made where every element is crucial. The most known example of a prognostic factor in HGG is the MGMT promoter methylation status and the response to alkylating agent chemotherapy, but many others are now under consideration in laboratory and clinical practice. From the first radiological evaluation to supportive end-of-life care, outcome assessment and prevision are of the utmost importance in HGG patient’s management to avoid both under or over treatments. This Special Issue will focus on the recent evidence on HGG’s Quoad vitam prognosis (prognostic radiological, clinical, biological, and genetical markers) and Quoad valetudinem prognosis (neurological and functional assessment of HGG patients, before and after therapy, including the psycho-social well-being of patients and caregivers).
Dr. Alba Scerrati
Dr. Giorgio Mantovani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- high-grade glioma
- outcome assessment
- prognostic factors
- neuro-oncology
- glioblastoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
